LB PHARMACEUTICALS INC financial data

Symbol
LBRX on Nasdaq
Location
New York, NY
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 06 Nov 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 25,299,102 shares
Common Stock, Shares, Outstanding 25,299,102 shares
Common Stock, Value, Issued $3,000 USD
Weighted Average Number of Shares Outstanding, Basic 5,806,862 shares 1517%
Weighted Average Number of Shares Outstanding, Diluted 5,806,862 shares 1517%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $2,419,000 USD -77%
General and Administrative Expense $2,827,000 USD -48%
Nonoperating Income (Expense) $1,690,000 USD -11%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $3,556,000 USD 75%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $3,556,000 USD 75%
Earnings Per Share, Basic -0.61 USD/shares 98%
Earnings Per Share, Diluted -0.61 USD/shares 98%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $269,744,000 USD
Marketable Securities, Current $44,735,000 USD
Cash, Cash Equivalents, and Short-term Investments $314,500,000 USD
Assets, Current $316,401,000 USD
Property, Plant and Equipment, Net $1,635,000 USD
Operating Lease, Right-of-Use Asset $2,198,000 USD
Assets $320,746,000 USD
Accounts Payable, Current $2,590,000 USD
Accrued Liabilities, Current $3,327,000 USD
Liabilities, Current $6,647,000 USD
Operating Lease, Liability, Noncurrent $2,936,000 USD
Liabilities $10,525,000 USD
Accumulated Other Comprehensive Income (Loss), Net of Tax $53,000 USD
Retained Earnings (Accumulated Deficit) $118,056,000 USD
Stockholders' Equity Attributable to Parent $310,221,000 USD
Liabilities and Equity $320,746,000 USD

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 500,000,000 shares
Common Stock, Shares, Issued 25,299,102 shares
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $270,256,000 USD
Operating Lease, Liability $3,666,000 USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $3,609,000 USD 75%
Lessee, Operating Lease, Liability, to be Paid $4,926,000 USD
Property, Plant and Equipment, Gross $1,972,000 USD
Operating Lease, Liability, Current $730,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year Two $730,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year One $730,000 USD
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1,260,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year Three $764,000 USD
Preferred Stock, Shares Authorized 10,000,000 shares
Lessee, Operating Lease, Liability, to be Paid, Year Four $775,000 USD
Operating Lease, Payments $183,000 USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares